Loading...
The effects of ultra-selective beta1-antagonism on the metabolic and cytokine profile in septic shock patients receiving noradrenaline: a sub-investigation from the STRESS-L Randomised Study
Thomas, Jarrod L. McGee, Kirsty C. Hossain, Anower Perkins, Gavin D. Gordon, Anthony C. Young, Duncan McAuley, Danny Singer, Mervyn Lall, Ranjit Kramaric, Tina
Thomas, Jarrod L.
McGee, Kirsty C.
Hossain, Anower
Perkins, Gavin D.
Gordon, Anthony C.
Young, Duncan
McAuley, Danny
Singer, Mervyn
Lall, Ranjit
Kramaric, Tina
Editors
Other contributors
Epub Date
Issue Date
2025-01-22
Submitted date
Files
Loading...
Published version
Adobe PDF, 1.19 MB
Alternative
Abstract
Purpose: The landiolol and organ failure in patients with septic shock (STRESS-L study) included a pre-planned sub-study to assess the effect of landiolol treatment on inflammatory and metabolomic markers. Methods: Samples collected from 91 patients randomised to STRESS-L were profiled for immune and metabolomic markers. A panel of pro- and anti-inflammatory cytokines were measured through commercially acquired multiplex Luminex assays and statistically analysed by individual and cluster-level analysis (patient). Metabolite fingerprinting was carried out by flow infusion electrospray ionisation high-resolution mass spectrometry and metabolomic data were analysed using the R-based platform MetaboAnalyst. The metabolites were identified using DIMEdb (dimedb.ibers.aber.ac.uk) from their mass/charge ratios. These metabolomic data were also re-analysed using individual and cluster-level analysis. The individual-level models were adjusted for confounders, such as age, sex, noradrenaline dosage and patient (random effect). Results: Analysis was undertaken at cluster- and individual-level. There were no significant differences in cytokine concentration level between trial arms nor survivors and non-survivors over the duration of the observations from day 1 to day 4. Metabolomic analysis showed some separation in the levels of ceramides and cardiolipins between those who survived and those who died. Following adjusted analysis for confounders, plasma metabolite concentrations remained statistically different between landiolol and standard care arms for succinic acid, l-tryptophan, l-alanine, 2,2,2-trichloroethanol, lactic acid and d-glucose. Conclusions: In a study of ICU patients with established septic shock and a tachycardia, landiolol treatment used to reduce the heart rate from above 95 to a range between 80 and 94 beats per minute did not induce significant cytokine changes. d-Glucose, lactic acid, succinic acid, l-alanine, l-tryptophan and trichloroethanol were pathways that may merit further investigation. Trial Registration: EU Clinical Trials Register Eudra CT: 2017-001785-14 (https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001785-14/GB); ISRCTN registry Identifier: ISRCTN12600919 (https://www.isrctn.com/ISRCTN12600919).
Citation
Thomas, J.L., McGee, K.C., Hossain, A. et al. The effects of ultra-selective beta1-antagonism on the metabolic and cytokine profile in septic shock patients receiving noradrenaline: a sub-investigation from the STRESS-L Randomised Study. Intensive Care Medical Experimental 13, 9 (2025). https://doi.org/10.1186/s40635-024-00708-6
Publisher
Research Unit
PubMed ID
39841388 (pubmed)
PubMed Central ID
Embedded videos
Additional Links
Type
Journal article
Language
en
Description
© 2025 The authors. Published by Springer Nature. This is an open access article available under a Creative Commons licence.
The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.1186/s40635-024-00708-6
Series/Report no.
ISSN
2197-425X
EISSN
2197-425X
ISBN
ISMN
Gov't Doc #
Sponsors
Funding was provided by grant 14/150/85 from the NIHR Efficacy and Mechanism Evaluation (EME).